NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

ConferenceNeutral

AI Analysis

Summary

NurExone announced plans for CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to participate in four major Boston life sciences events to engage with industry, investors, and scientific leaders.

Importance:2/10

Sentiment:

0.00

ConferenceCorporate UpdateBostonInvestor Engagement

Read the original article

Published by GlobeNewswire Pharma on September 18, 2026 8:21 PM

Read Original